Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.
Krönig M, Haverkamp C, Schulte A, Heinicke L, Schaal K, Drendel V, Werner M, Wetterauer U, Schultze-Seemann W, Jilg CA.
Krönig M, et al. Among authors: schulte a.
World J Surg Oncol. 2017 Feb 21;15(1):50. doi: 10.1186/s12957-017-1117-4.
World J Surg Oncol. 2017.
PMID: 28222734
Free PMC article.